{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:01:51Z","timestamp":1774119711618,"version":"3.50.1"},"reference-count":124,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.semarthrit.2010.08.004","type":"journal-article","created":{"date-parts":[[2010,11,3]],"date-time":"2010-11-03T08:12:51Z","timestamp":1288771971000},"page":"19-37","source":"Crossref","is-referenced-by-count":37,"title":["Pulmonary Hypertension in Systemic Sclerosis"],"prefix":"10.1016","volume":"41","author":[{"given":"Soumya","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2010.08.004_bib1","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.08.004_bib2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1378\/chest.123.2.344","article-title":"Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis","volume":"123","author":"Kawut","year":"2003","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.semarthrit.2010.08.004_bib3","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1002\/art.22069","article-title":"Clinical differences between idiopathic and scleroderma-related pulmonary hypertension","volume":"54","author":"Fisher","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2010.08.004_bib4","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.21433","article-title":"Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study","volume":"52","author":"Hachulla","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.semarthrit.2010.08.004_bib5","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/ard.62.11.1088","article-title":"Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach","volume":"62","author":"Mukerjee","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2010.08.004_bib6","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1445-5994.2008.01823.x","article-title":"Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis","volume":"39","author":"Phung","year":"2009","journal-title":"Intern Med J"},{"issue":"7","key":"10.1016\/j.semarthrit.2010.08.004_bib7","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.semarthrit.2010.08.004_bib8","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1002\/art.21131","article-title":"The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study)","volume":"52","author":"Wigley","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.08.004_bib9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","article-title":"Primary pulmonary hypertension","volume":"107","author":"Rich","year":"1987","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2010.08.004_bib10","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jacc.2009.04.011","article-title":"Diagnosis and assessment of pulmonary arterial hypertension","volume":"54","author":"Badesch","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.semarthrit.2010.08.004_bib11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00392-007-0526-8","article-title":"Pulmonary hypertension: current diagnosis and treatment","volume":"96","author":"Rosenkranz","year":"2007","journal-title":"Clin Res Cardiol"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.08.004_bib12","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1183\/09031936.00139009","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"34","author":"Galie","year":"2009","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.08.004_bib13","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/art.10775","article-title":"Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement","volume":"48","author":"Steen","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.08.004_bib14","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1378\/chest.124.6.2098","article-title":"Age and risk of pulmonary arterial hypertension in scleroderma","volume":"124","author":"Schachna","year":"2003","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.08.004_bib15","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1378\/chest.08-3042","article-title":"Is pulmonary arterial hypertension really a late complication of systemic sclerosis?","volume":"136","author":"Hachulla","year":"2009","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.08.004_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/rheumatology\/36.2.239","article-title":"Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis","volume":"36","author":"Denton","year":"1997","journal-title":"Br J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.08.004_bib17","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.1378\/chest.08-0053","article-title":"Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survival","volume":"134","author":"Fischer","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.semarthrit.2010.08.004_bib18","series-title":"Systemic sclerosis","first-page":"184","article-title":"Pulmonary fibrosis and pulmonary vascular involvement in systemic sclerosis: 9b","author":"Denton","year":"2004"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.08.004_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/CRD.0b013e3181cbcde7","article-title":"Pulmonary arterial hypertension in connective tissue diseases","volume":"18","author":"Goldberg","year":"2010","journal-title":"Cardiol Rev"},{"issue":"9434","key":"10.1016\/j.semarthrit.2010.08.004_bib20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(04)16853-0","article-title":"Defective vasculogenesis in systemic sclerosis","volume":"364","author":"Kuwana","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.08.004_bib21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0046-8177(90)90002-M","article-title":"The pulmonary pathologic manifestations of the CREST syndrome","volume":"21","author":"Yousem","year":"1990","journal-title":"Hum Pathol"},{"issue":"8","key":"10.1016\/j.semarthrit.2010.08.004_bib22","first-page":"1038","article-title":"Pulmonary arterial histology and morphometry in systemic sclerosis: a case-control autopsy study","volume":"16","author":"al Sabbagh","year":"1989","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.08.004_bib23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1136\/ard.57.5.296","article-title":"Heart involvement in systemic sclerosis: an ultrasonic tissue characterisation study","volume":"57","author":"Ferri","year":"1998","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.08.004_bib24","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/art.23463","article-title":"Cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography during routine care: a controlled study of 100 consecutive patients","volume":"58","author":"Meune","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2010.08.004_bib25","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.090931","article-title":"Early detection of cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography: relationship with neurohormonal activation and endothelial dysfunction","author":"Dimitroulas","year":"2010","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.08.004_bib26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/ard.59.2.94","article-title":"Right ventricular diastolic abnormalities in systemic sclerosis","volume":"59","author":"Giunta","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.semarthrit.2010.08.004_bib27","first-page":"2431","article-title":"Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis","volume":"34","author":"Bezante","year":"2007","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2010.08.004_bib28","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1136\/ard.2008.095836","article-title":"Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients","volume":"68","author":"Hachulla","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.08.004_bib29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1054\/jcaf.2003.51","article-title":"Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study","volume":"9","author":"Fernandes","year":"2003","journal-title":"J Card Fail"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.08.004_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/ard.2006.057760","article-title":"Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis","volume":"67","author":"de Groote","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.semarthrit.2010.08.004_bib31","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/art.1780390710","article-title":"Comprehensive noninvasive assessment of cardiac involvement in limited systemic sclerosis","volume":"39","author":"Candell-Riera","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.08.004_bib32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1378\/chest.91.1.118","article-title":"Cardiopulmonary manifestations of systemic sclerosis","volume":"91","author":"Owens","year":"1987","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.08.004_bib33","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1183\/09031936.00135407","article-title":"Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension","volume":"31","author":"Overbeek","year":"2008","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.08.004_bib34","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0002-9343(69)90044-8","article-title":"Pathologic observations in systemic sclerosis (scleroderma)","volume":"46","author":"D'Angelo","year":"1969","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.08.004_bib35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-73-2-317","article-title":"Vascular disease in progressive systemic sclerosis (scleroderma)","volume":"73","author":"Norton","year":"1970","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.08.004_bib36","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0046-8177(97)90032-0","article-title":"Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection","volume":"28","author":"Cool","year":"1997","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.08.004_bib37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1183\/09031936.00106008","article-title":"Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy","volume":"34","author":"Overbeek","year":"2009","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.08.004_bib38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1183\/09031936.00081009","article-title":"Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension","volume":"35","author":"Dorfmuller","year":"2010","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.semarthrit.2010.08.004_bib39","first-page":"1055","article-title":"Pulmonary veno-occlusive disease and the CREST variant of scleroderma","volume":"8","author":"Morassut","year":"1992","journal-title":"Can J Cardiol"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.08.004_bib40","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1440-1843.2003.00451.x","article-title":"A case of pulmonary veno-occlusive disease associated with systemic sclerosis","volume":"8","author":"Saito","year":"2003","journal-title":"Respirology"},{"issue":"11","key":"10.1016\/j.semarthrit.2010.08.004_bib41","first-page":"2347","article-title":"Pulmonary veno-occlusive disease and scleroderma associated pulmonary hypertension","volume":"33","author":"Johnson","year":"2006","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.08.004_bib42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1378\/chest.113.1.237","article-title":"Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease","volume":"113","author":"Palmer","year":"1998","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.08.004_bib43","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.humpath.2006.11.022","article-title":"Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases","volume":"38","author":"Dorfmuller","year":"2007","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.08.004_bib44","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/1089253207301355","article-title":"Clinical presentation, differential diagnosis, and vasodilator testing of pulmonary hypertension","volume":"11","author":"Edelman","year":"2007","journal-title":"Semin Cardiothorac Vasc Anesth"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.08.004_bib45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1164\/rccm.200806-953OC","article-title":"Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era","volume":"179","author":"Condliffe","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.08.004_bib46","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/art.24267","article-title":"Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease","volume":"60","author":"Mathai","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"21","key":"10.1016\/j.semarthrit.2010.08.004_bib47","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1161\/CIRCULATIONAHA.108.787101","article-title":"Exercise-induced pulmonary arterial hypertension","volume":"118","author":"Tolle","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.08.004_bib48","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1378\/chest.07-2324","article-title":"Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis","volume":"134","author":"Steen","year":"2008","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.semarthrit.2010.08.004_bib49","first-page":"1812","article-title":"Prevalence of exercise pulmonary arterial hypertension in scleroderma","volume":"35","author":"Callejas-Rubio","year":"2008","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.08.004_bib50","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1183\/09031936.00145608","article-title":"Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review","volume":"34","author":"Kovacs","year":"2009","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.08.004_bib51","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1152\/jappl.1993.74.4.1666","article-title":"Mechanisms of improved arterial oxygenation after peripheral chemoreceptor stimulation during hypoxic exercise","volume":"74","author":"Naeije","year":"1993","journal-title":"J Appl Physiol"},{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2010.08.004_bib52","doi-asserted-by":"crossref","first-page":"78S","DOI":"10.1378\/chest.126.1_suppl.78S","article-title":"Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines","volume":"126","author":"McLaughlin","year":"2004","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.08.004_bib53","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension","volume":"115","author":"D'Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.08.004_bib54","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1161\/01.CIR.89.4.1733","article-title":"Survival in primary pulmonary hypertension","volume":"89","author":"Sandoval","year":"1994","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.08.004_bib55","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2169\/internalmedicine.38.12","article-title":"Prediction of life expectancy in patients with primary pulmonary hypertension","volume":"38","author":"Okada","year":"1999","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.08.004_bib56","first-page":"165","article-title":"Primary pulmonary hypertension: natural history and prognostic factors","volume":"46","author":"Rajasekhar","year":"1994","journal-title":"Indian Heart J"},{"issue":"10","key":"10.1016\/j.semarthrit.2010.08.004_bib57","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/rheumatology\/35.10.989","article-title":"Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients","volume":"35","author":"Koh","year":"1996","journal-title":"Br J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.08.004_bib58","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1191\/0961203306lu2280rr","article-title":"Connective tissue associated pulmonary arterial hypertension","volume":"15","author":"Coghlan","year":"2006","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.08.004_bib59","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/rheumatology\/kep398","article-title":"Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil","volume":"49","author":"Launay","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 3","key":"10.1016\/j.semarthrit.2010.08.004_bib60","doi-asserted-by":"crossref","first-page":"iii25","DOI":"10.1093\/rheumatology\/kep107","article-title":"Pulmonary arterial hypertension: the most devastating vascular complication of systemic sclerosis","volume":"48","author":"McLaughlin","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.semarthrit.2010.08.004_bib61","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1445-5994.2007.01370.x","article-title":"Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment","volume":"37","author":"Proudman","year":"2007","journal-title":"Intern Med J"},{"issue":"2 Pt. 1","key":"10.1016\/j.semarthrit.2010.08.004_bib62","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1164\/ajrccm.161.2.9906015","article-title":"Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension","volume":"161","author":"Miyamoto","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.semarthrit.2010.08.004_bib63","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1445-5994.2008.01880.x","article-title":"The six-minute walk test: a useful metric for the cardiopulmonary patient","volume":"39","author":"Rasekaba","year":"2009","journal-title":"Intern Med J"},{"issue":"Suppl 5","key":"10.1016\/j.semarthrit.2010.08.004_bib64","doi-asserted-by":"crossref","first-page":"v68","DOI":"10.1093\/rheumatology\/ken273","article-title":"The 6-minute walk test in scleroderma\u2014how measuring everything measures nothing","volume":"47","author":"Impens","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.08.004_bib65","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/ard.2006.054866","article-title":"Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test","volume":"66","author":"Buch","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.08.004_bib66","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3899\/jrheum.080447","article-title":"Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma","volume":"36","author":"Garin","year":"2009","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.08.004_bib67","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3899\/jrheum.081243","article-title":"Six-minute walk test in scleroderma-associated pulmonary arterial hypertension: are we counting what counts?","volume":"36","author":"Pamidi","year":"2009","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2010.08.004_bib68","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3899\/jrheum.081221","article-title":"Lack of specificity of the 6-minute walk test as an outcome measure for patients with systemic sclerosis","volume":"36","author":"Schoindre","year":"2009","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.08.004_bib69","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/BOR.0b013e3283307dc8","article-title":"Therapy for pulmonary arterial hypertension associated with systemic sclerosis","volume":"21","author":"Mathai","year":"2009","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.08.004_bib70","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1378\/chest.06-0630","article-title":"Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients","volume":"131","author":"Villalba","year":"2007","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.08.004_bib71","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.semarthrit.2009.03.005","article-title":"Natriuretic peptides in systemic sclerosis-related pulmonary arterial hypertension","volume":"39","author":"Dimitroulas","year":"2010","journal-title":"Semin Arthritis Rheum"},{"issue":"3 Suppl 54","key":"10.1016\/j.semarthrit.2010.08.004_bib72","first-page":"59","article-title":"N-terminal pro brain natriuretic peptide: the new cornerstone of cardiovascular assessment in systemic sclerosis","volume":"27","author":"Allanore","year":"2009","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2010.08.004_bib73","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0954-6111(03)00254-3","article-title":"Significance of plasma N-terminal pro-brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension","volume":"97","author":"Mukerjee","year":"2003","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.08.004_bib74","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1183\/09031936.00160307","article-title":"Biomarkers in pulmonary hypertension","volume":"32","author":"Warwick","year":"2008","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.semarthrit.2010.08.004_bib75","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.clinbiochem.2006.03.016","article-title":"Evaluation of cardiac laboratory markers in patients with systemic sclerosis","volume":"39","author":"Montagnana","year":"2006","journal-title":"Clin Biochem"},{"issue":"12","key":"10.1016\/j.semarthrit.2010.08.004_bib76","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1136\/ard.2008.098087","article-title":"N-terminal pro-brain natriuretic peptide in systemic sclerosis: a new cornerstone of cardiovascular assessment?","volume":"68","author":"Allanore","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.semarthrit.2010.08.004_bib77","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1002\/art.11345","article-title":"N-terminal pro-brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium-channel blockers","volume":"48","author":"Allanore","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.08.004_bib78","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/art.23187","article-title":"High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis","volume":"58","author":"Allanore","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2010.08.004_bib79","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/eurheartj\/ehi891","article-title":"Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension","volume":"27","author":"Williams","year":"2006","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.08.004_bib80","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0735-1097(02)02059-4","article-title":"Plasma brain natriuretic peptide concentration: impact of age and gender","volume":"40","author":"Redfield","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.semarthrit.2010.08.004_bib81","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/CIRCULATIONAHA.105.555573","article-title":"Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study","volume":"112","author":"Das","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.08.004_bib82","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1378\/chest.06-1758","article-title":"N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension","volume":"131","author":"Leuchte","year":"2007","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.08.004_bib83","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1183\/09031936.00074309","article-title":"Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension","volume":"35","author":"Mathai","year":"2010","journal-title":"Eur Respir J"},{"issue":"23","key":"10.1016\/j.semarthrit.2010.08.004_bib84","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","volume":"111","author":"Sitbon","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.08.004_bib85","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s005350050008","article-title":"Effect of nifedipine administration (10 mg) on esophageal acid exposure time","volume":"35","author":"Ishikawa","year":"2000","journal-title":"J Gastroenterol"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.08.004_bib86","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1378\/chest.06-2674","article-title":"Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines","volume":"131","author":"Badesch","year":"2007","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.08.004_bib87","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1191\/0961203306lu2280rr","article-title":"Connective tissue associated pulmonary arterial hypertension","volume":"15","author":"Coghlan","year":"2006","journal-title":"Lupus"},{"issue":"16","key":"10.1016\/j.semarthrit.2010.08.004_bib88","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/CIRCULATIONAHA.109.192230","volume":"119","author":"McLaughlin","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.08.004_bib89","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.CIR.70.4.580","article-title":"Primary pulmonary hypertension: natural history and the importance of thrombosis","volume":"70","author":"Fuster","year":"1984","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.08.004_bib90","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.semarthrit.2010.08.004_bib91","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3949\/ccjm.74.11.789","article-title":"Treating pulmonary arterial hypertension: cautious hope in a deadly disease","volume":"74","author":"Minai","year":"2007","journal-title":"Cleve Clin J Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.08.004_bib92","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/01.rhu.0000081257.17469.4d","article-title":"Refractory pulmonary hypertension in a lupus patient with occult pulmonary vasculitis","volume":"9","author":"Srock","year":"2003","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.08.004_bib93","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1378\/chest.130.1.182","article-title":"Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension","volume":"130","author":"Sanchez","year":"2006","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.semarthrit.2010.08.004_bib94","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1177\/0961203306070976","article-title":"Association of nodular regenerative hyperplasia of the liver with porto-pulmonary hypertension in a patient with systemic lupus erythematosus","volume":"15","author":"Park","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2010.08.004_bib95","doi-asserted-by":"crossref","DOI":"10.1378\/chest.10-0260","article-title":"Characterization of connective tissue disease associated pulmonary arterial hypertension from the REVEAL registry: identifying systemic sclerosis as a unique phenotype","author":"Chung","year":"2010","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.08.004_bib96","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.08.004_bib97","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/1529-0131(199803)41:3<466::AID-ART13>3.0.CO;2-O","article-title":"The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis","volume":"41","author":"Menon","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2010.08.004_bib98","doi-asserted-by":"crossref","first-page":"80S","DOI":"10.1378\/chest.114.1_Supplement.80S","article-title":"Treatment of severe pulmonary hypertension secondary to connective tissue diseases with continuous IV epoprostenol (prostacyclin)","volume":"114","author":"Humbert","year":"1998","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.semarthrit.2010.08.004_bib99","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/1529-0131(199912)42:12<2638::AID-ANR20>3.0.CO;2-X","article-title":"Systemic sclerosis-associated pulmonary hypertension: short- and long-term effects of epoprostenol (prostacyclin)","volume":"42","author":"Klings","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.08.004_bib100","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.08.004_bib101","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1053\/pcad.2002.129975","article-title":"Pulmonary hypertension associated with connective tissue disease","volume":"45","author":"Fagan","year":"2002","journal-title":"Prog Cardiovasc Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.08.004_bib102","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial","volume":"165","author":"Simonneau","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.08.004_bib103","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1378\/chest.126.2.420","article-title":"Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease","volume":"126","author":"Oudiz","year":"2004","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.08.004_bib104","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00005344-200408000-00010","article-title":"Pharmacokinetics and steady-state bioequivalence of treprostinil sodium (Remodulin) administered by the intravenous and subcutaneous route to normal volunteers","volume":"44","author":"Laliberte","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.08.004_bib105","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1378\/chest.129.3.683","article-title":"Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial","volume":"129","author":"Tapson","year":"2006","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.semarthrit.2010.08.004_bib106","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost for severe pulmonary hypertension","volume":"347","author":"Olschewski","year":"2002","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.semarthrit.2010.08.004_bib107","first-page":"2252","article-title":"Aerosolized iloprost in CREST syndrome related pulmonary hypertension","volume":"28","author":"Launay","year":"2001","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.08.004_bib108","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1054\/plef.2002.0380","article-title":"Long-term administration of beraprost, an oral prostacyclin analogue, improves pulmonary diffusion capacity in patients with systemic sclerosis","volume":"67","author":"Matsukawa","year":"2002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"9288","key":"10.1016\/j.semarthrit.2010.08.004_bib109","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.semarthrit.2010.08.004_bib110","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"10.1016\/j.semarthrit.2010.08.004_bib111","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2362.2006.01684.x","article-title":"Bosentan therapy of pulmonary arterial hypertension in connective tissue diseases","volume":"36","author":"Cozzi","year":"2006","journal-title":"Eur J Clin Invest"},{"issue":"10","key":"10.1016\/j.semarthrit.2010.08.004_bib112","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.jacc.2006.01.057","article-title":"Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan","volume":"47","author":"Barst","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.semarthrit.2010.08.004_bib113","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jacc.2005.04.050","article-title":"Ambrisentan therapy for pulmonary arterial hypertension","volume":"46","author":"Galie","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.semarthrit.2010.08.004_bib114","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Galie","year":"2005","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.semarthrit.2010.08.004_bib115","first-page":"2417","article-title":"Sildenafil for pulmonary arterial hypertension associated with connective tissue disease","volume":"34","author":"Badesch","year":"2007","journal-title":"J Rheumatol"},{"issue":"22","key":"10.1016\/j.semarthrit.2010.08.004_bib116","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension","volume":"119","author":"Galie","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.08.004_bib117","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/eurheartj\/ehp022","article-title":"A meta-analysis of randomized controlled trials in pulmonary arterial hypertension","volume":"30","author":"Galie","year":"2009","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.08.004_bib118","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/00151829-200403060-00002","article-title":"Pulmonary arterial hypertension in systemic sclerosis: clinical manifestations, pathophysiology, evaluation, and management","volume":"3","author":"Ramirez","year":"2004","journal-title":"Treat Respir Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.08.004_bib119","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/thorax.55.2.95","article-title":"Role of atrial septostomy in the treatment of pulmonary vascular disease","volume":"55","author":"Barst","year":"2000","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.semarthrit.2010.08.004_bib120","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/1529-0131(200107)44:7<1660::AID-ART289>3.0.CO;2-W","article-title":"Palliation of systemic sclerosis-associated pulmonary hypertension by atrial septostomy","volume":"44","author":"Allcock","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.08.004_bib121","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.hlc.2006.02.002","article-title":"Insertion of a fenestrated Amplatzer atrial septostomy device for severe pulmonary hypertension","volume":"15","author":"O'Loughlin","year":"2006","journal-title":"Heart Lung Circ"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.08.004_bib122","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1399-0012.2009.00958.x","article-title":"Lung transplantation in patients with scleroderma: case series, review of the literature, and criteria for transplantation","volume":"23","author":"Shitrit","year":"2009","journal-title":"Clin Transplant"},{"issue":"11","key":"10.1016\/j.semarthrit.2010.08.004_bib123","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1007\/s00268-005-0017-x","article-title":"Outcomes of lung transplantation in patients with scleroderma","volume":"29","author":"Massad","year":"2005","journal-title":"World J Surg"},{"issue":"12","key":"10.1016\/j.semarthrit.2010.08.004_bib124","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1002\/art.22264","article-title":"Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension","volume":"54","author":"Schachna","year":"2006","journal-title":"Arthritis Rheum"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017210001769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017210001769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T01:55:13Z","timestamp":1559786113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017210001769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":124,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0049017210001769"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2010.08.004","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}